Pipeline Therapeutics

OverviewSuggest Edit

Pipeline Therapeutics is a neuroscience company. It is engaged in synaptogenesis, remyelination, and axonal repair. The company deals with CNS drug discovery and harnessing relationships with academics in key CNS areas of growing pharma interest.
TypePrivate
Founded2017
HQSan Diego, CA, US
Websitepipelinetherapeutics.com

Latest Updates

Employees (est.) (Sept 2021)27
Cybersecurity ratingBMore

Key People/Management at Pipeline Therapeutics

Thomas O. Schrader

Thomas O. Schrader

Director of Chemistry
Karin Stebbins

Karin Stebbins

Senior Director, Biology
Yifeng Xiong

Yifeng Xiong

Director of Chemistry
Mike Poon

Mike Poon

Senior Director, Biology
Tara Vargas

Tara Vargas

Senior Director, Project Management
Carmine Stengone

Carmine Stengone

President & CEO, Board Member
Show more

Pipeline Therapeutics Office Locations

Pipeline Therapeutics has an office in San Diego
San Diego, CA, US (HQ)
10578 Science Center Dr #200
Show all (1)

Pipeline Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Pipeline Therapeutics total Funding

$30 m

Pipeline Therapeutics latest funding size

$30 m

Time since last funding

2 years ago

Pipeline Therapeutics investors

Pipeline Therapeutics's latest funding round in December 2019 was reported to be $30 m. In total, Pipeline Therapeutics has raised $30 m
Show all financial metrics

Pipeline Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

81/100

SecurityScorecard logo

Pipeline Therapeutics Online and Social Media Presence

Embed Graph

Pipeline Therapeutics News and Updates

Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021

ERYtech Pharma, GlaxoSmithKline, Galera Therapeutics, Propanc and several others key companies are set to transform the Advanced Pancreatic Cancer Pipeline landscape in the coming years. ERYtech Pharma, GlaxoSmithKline, Galera Therapeutics, Propanc and several others key companies are set to transfo…

Lupus Pipeline Therapeutics Market Analysis Report by Goldstein Market Intelligence

According to Goldstein Market Intelligence, Lupus pipeline therapeutics market is expected to reach at a CAGR of 10.5% by 2030. Posted via Industry Today. Follow us on Twitter @IndustryToday

Pipeline Therapeutics Frequently Asked Questions

  • When was Pipeline Therapeutics founded?

    Pipeline Therapeutics was founded in 2017.

  • Who are Pipeline Therapeutics key executives?

    Pipeline Therapeutics's key executives are Thomas O. Schrader, Karin Stebbins and Yifeng Xiong.

  • How many employees does Pipeline Therapeutics have?

    Pipeline Therapeutics has 27 employees.

  • Who are Pipeline Therapeutics competitors?

    Competitors of Pipeline Therapeutics include Octapharma, McKesson Europe and CSPC Pharmaceutical Group.

  • Where is Pipeline Therapeutics headquarters?

    Pipeline Therapeutics headquarters is located at 10578 Science Center Dr #200, San Diego.

  • Where are Pipeline Therapeutics offices?

    Pipeline Therapeutics has an office in San Diego.

  • How many offices does Pipeline Therapeutics have?

    Pipeline Therapeutics has 1 office.